Clinical trials: Opisthorchis Viverrini
Dengue, Chikungunya
Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
RACSMEI addresses the high burden of infectious diseases in low- and middle-income countries, including Cambodia, where limited surveillance and laboratory capacity often obscure etiologies and transmission dynamics.
- Conditions
- Dengue, Chikungunya, Zika Virus Infection, Japanese Encephalitis
- Trial name
- RACSMEI (NCT07358910)
- Where
- Cambodia
- Volunteers
- 10,000 people, healthy volunteers welcome
- Sponsor
- Institut Pasteur du Cambodge
Opisthorchis Viverrini
Efficacy and Safety of Ascending Doses of Arpraziquantel in Children Infected With Opisthorchis Viverrini
This study aims to assess the efficacy, safety and acceptability of ascending doses of arpraziquantel in children infected with Opisthorchis viverrini.
- Trial name
- ADORA-VI (NCT07262814)
- Testing
- Apraziquantel
- Where
- Laos
- Volunteers
- 125 people
- Sponsor
- Jennifer Keiser
Opisthorchis Viverrini
Pathogenesis of Liver Fluke Induced Cancer in Thailand
Opisthorchis viverrini (OV) is a parasite that individuals get from eating raw fish. Infections with this parasite have been associated with liver abnormalities that sometimes lead to bile duct cancer.
- Trial name
- NCT00472602
- Where
- Thailand
- Volunteers
- 695 people
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)